Follow
Kevin Leder
Kevin Leder
Associate Professor of Industrial and Systems Engineering, University of Minnesota
Verified email at umn.edu
Title
Cited by
Cited by
Year
Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules
K Leder, K Pitter, Q LaPlant, D Hambardzumyan, BD Ross, TA Chan, ...
Cell 156 (3), 603-616, 2014
2962014
Intratumor heterogeneity in evolutionary models of tumor progression
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Genetics 188 (2), 461-477, 2011
1562011
A mathematical model of tumor growth and its response to single irradiation
Y Watanabe, EL Dahlman, KZ Leder, SK Hui
Theoretical Biology and Medical Modelling 13, 1-20, 2016
1152016
The impact of microenvironmental heterogeneity on the evolution of drug resistance in cancer cells
SM Mumenthaler, J Foo, NC Choi, N Heise, K Leder, DB Agus, W Pao, ...
Cancer informatics 14, CIN. S19338, 2015
1082015
Importance sampling for sums of random variables with regularly varying tails
P Dupuis, K Leder, H Wang
ACM Transactions on Modeling and Computer Simulation (TOMACS) 17 (3), 14-es, 2007
942007
Stochastic dynamics of cancer initiation
J Foo, K Leder, F Michor
Physical biology 8 (1), 015002, 2011
782011
Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia
K Leder, J Foo, B Skaggs, M Gorre, CL Sawyers, F Michor
PloS one 6 (11), e27682, 2011
702011
Evolutionary dynamics of tumor progression with random fitness values
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Theoretical population biology 78 (1), 54-66, 2010
692010
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer
SM Mumenthaler, J Foo, K Leder, NC Choi, DB Agus, W Pao, P Mallick, ...
Molecular pharmaceutics 8 (6), 2069-2079, 2011
662011
The therapeutic implications of plasticity of the cancer stem cell phenotype
K Leder, EC Holland, F Michor
PloS one 5 (12), e14366, 2010
632010
Understanding the role of phenotypic switching in cancer drug resistance
EB Gunnarsson, S De, K Leder, J Foo
Journal of theoretical biology 490, 110162, 2020
592020
Optimization of radiation dosing schedules for proneural glioblastoma
H Badri, K Pitter, EC Holland, F Michor, K Leder
Journal of mathematical biology 72, 1301-1336, 2016
582016
Quantifying the dynamics of field cancerization in tobacco-related head and neck cancer: a multiscale modeling approach
MD Ryser, WT Lee, NE Ready, KZ Leder, J Foo
Cancer research 76 (24), 7078-7088, 2016
482016
Spatial Moran models, II: cancer initiation in spatially structured tissue
R Durrett, J Foo, K Leder
Journal of mathematical biology 72, 1369-1400, 2016
47*2016
Multifocality and recurrence risk: a quantitative model of field cancerization
J Foo, K Leder, MD Ryser
Journal of theoretical biology 355, 170-184, 2014
452014
Optimal radiotherapy dose schedules under parametric uncertainty
H Badri, Y Watanabe, K Leder
Physics in Medicine & Biology 61 (1), 338, 2015
36*2015
Efficient simulation of light-tailed sums: an old-folk song sung to a faster new tune...
JH Blanchet, K Leder, PW Glynn
Monte Carlo and Quasi-Monte Carlo Methods 2008, 227-248, 2009
36*2009
Dynamics of cancer recurrence
J Foo, K Leder
352013
An evolutionary approach for identifying driver mutations in colorectal cancer
J Foo, LL Liu, K Leder, M Riester, Y Iwasa, C Lengauer, F Michor
PLoS computational biology 11 (9), e1004350, 2015
332015
Large deviations and importance sampling for a tandem network with slow-down
P Dupuis, K Leder, H Wang
Queueing Systems 57 (2), 71-83, 2007
312007
The system can't perform the operation now. Try again later.
Articles 1–20